Autopsy report · NCT03796403

Bupivacaine Plus Diclofenac Versus Bupivacaine Alone for Postoperative Pain Relief in Gynecologic Cancer Patients

Cause of deathOther Automatic label, confidence 0.3, unverified. How labels are made.

“Diclofenac is no longer recommend for intramuscular administration by the Medical Council of Thailand”

The sponsor’s own words in the registry.

Life of this trial

Registered 5 months before it started.
Ran for about 10 months before it stopped.
140 participants enrolled.
No results are posted on the registry.

Vital statistics

Status: Terminated
Phase: Na
Sponsor: Department of Medical Services Ministry of Public Health of Thailand
Sponsor type: Government (non-US federal)
Conditions: Post-operative Pain
Interventions: Diclofenac
Participants: 140
Sites: 1
Countries: Thailand

Look deeper

The official registry record (the source of truth)
Record history: every change the sponsor made
Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.